Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
11
Published: Aug. 11, 2020
Evidence
from
the
global
outbreak
of
SARS-CoV-2
has
clearly
demonstrated
that
individuals
with
pre-existing
comorbidities
are
at
a
much
greater
risk
dying
COVID-19.
This
is
great
concern
for
living
these
conditions,
and
major
challenge
healthcare
systems
biomedical
research.
Not
all
confer
same
risk,
however,
many
affect
function
immune
system,
which
in
turn
directly
impacts
response
to
Furthermore,
myriad
drugs
prescribed
can
also
influence
progression
COVID-19
limit
additional
treatment
options
available
Here,
we
review
dysfunction
infection
impact
on
development
We
explore
how
underlying
disease
etiologies
common
therapies
used
treat
conditions
exacerbate
progression.
Moreover,
discuss
long-term
challenges
associated
use
both
novel
repurposed
patients
comorbidities.
The Lancet,
Journal Year:
2020,
Volume and Issue:
395(10239), P. 1771 - 1778
Published: May 13, 2020
BackgroundThe
Bergamo
province,
which
is
extensively
affected
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
epidemic,
a
natural
observatory
of
virus
manifestations
in
general
population.
In
past
month
we
recorded
an
outbreak
Kawasaki
disease;
aimed
to
evaluate
incidence
and
features
patients
with
Kawasaki-like
disease
diagnosed
during
SARS-CoV-2
epidemic.MethodsAll
at
our
centre
5
years
were
divided
according
symptomatic
presentation
before
(group
1)
or
after
2)
beginning
epidemic.
Kawasaki-
like
presentations
managed
as
American
Heart
Association
indications.
shock
(KDSS)
was
defined
presence
circulatory
dysfunction,
macrophage
activation
(MAS)
Paediatric
Rheumatology
International
Trials
Organisation
criteria.
Current
previous
infection
sought
reverse-transcriptase
quantitative
PCR
nasopharyngeal
oropharyngeal
swabs,
serological
qualitative
test
detecting
IgM
IgG,
respectively.FindingsGroup
1
comprised
19
(seven
boys,
12
girls;
aged
3·0
[SD
2·5])
between
Jan
1,
2015,
Feb
17,
2020.
Group
included
ten
three
7·5
3·5])
18
April
20,
2020;
eight
positive
for
IgG
IgM,
both.
The
two
groups
differed
vs
group
2,
0·3
per
month),
mean
age
(3·0
years),
cardiac
involvement
(two
six
ten),
KDSS
(zero
five
MAS
need
adjunctive
steroid
treatment
(three
ten;
all
p<0·01).InterpretationIn
found
30-fold
increased
disease.
Children
epidemic
began
showed
evidence
immune
response
virus,
older,
had
higher
rate
involvement,
MAS.
associated
high
form
A
similar
expected
countries
involved
epidemic.FundingNone.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Dec. 9, 2020
Abstract
Anecdotal
evidence
suggests
that
Coronavirus
disease
2019
(COVID-19),
caused
by
the
coronavirus
SARS-CoV-2,
exhibits
differences
in
morbidity
and
mortality
between
sexes.
Here,
we
present
a
meta-analysis
of
3,111,714
reported
global
cases
to
demonstrate
that,
whilst
there
is
no
difference
proportion
males
females
with
confirmed
COVID-19,
male
patients
have
almost
three
times
odds
requiring
intensive
treatment
unit
(ITU)
admission
(OR
=
2.84;
95%
CI
2.06,
3.92)
higher
death
1.39;
1.31,
1.47)
compared
females.
With
few
exceptions,
sex
bias
observed
COVID-19
worldwide
phenomenon.
An
appreciation
how
influencing
outcomes
will
important
implications
for
clinical
management
mitigation
strategies
this
disease.
New England Journal of Medicine,
Journal Year:
2020,
Volume and Issue:
383(25), P. 2451 - 2460
Published: May 15, 2020
Key
Clinical
Points
Evaluation
and
Management
of
Severe
Covid-19
Patients
with
severe
coronavirus
disease
2019
(Covid-19)
may
become
critically
ill
acute
respiratory
distress
syndrome
that
typ...
JAMA,
Journal Year:
2020,
Volume and Issue:
324(7), P. 663 - 663
Published: July 24, 2020
Severe
coronavirus
disease
2019
(COVID-19)
can
occur
in
younger,
predominantly
male,
patients
without
preexisting
medical
conditions.
Some
individuals
may
have
primary
immunodeficiencies
that
predispose
to
severe
infections
caused
by
acute
respiratory
syndrome
2
(SARS-CoV-2).To
explore
the
presence
of
genetic
variants
associated
with
among
young
COVID-19.Case
series
pairs
brothers
history
meeting
selection
criteria
(age
<35
years)
brother
admitted
intensive
care
unit
(ICU)
due
COVID-19.
Four
men
from
unrelated
families
were
ICUs
4
hospitals
Netherlands
between
March
23
and
April
12,
2020.
The
final
date
follow-up
was
May
16,
Available
family
members
included
for
variant
segregation
analysis
as
controls
functional
experiments.Severe
COVID-19.Results
rapid
clinical
whole-exome
sequencing,
performed
identify
a
potential
monogenic
cause.
Subsequently,
basic
immunological
tests
immune
cells
isolated
characterize
any
defects.The
male
had
mean
age
26
years
(range,
21-32),
no
major
chronic
disease.
They
previously
well
before
developing
insufficiency
COVID-19,
requiring
mechanical
ventilation
ICU.
duration
ventilatory
support
10
days
9-11);
ICU
stay
13
10-16).
One
patient
died.
Rapid
sequencing
available
identified
loss-of-function
X-chromosomal
TLR7.
In
1,
maternally
inherited
4-nucleotide
deletion
(c.2129_2132del;
p.[Gln710Argfs*18]);
affected
carried
missense
(c.2383G>T;
p.[Val795Phe]).
peripheral
blood
mononuclear
patients,
downstream
type
I
interferon
(IFN)
signaling
transcriptionally
downregulated,
measured
significantly
decreased
mRNA
expression
IRF7,
IFNB1,
ISG15
on
stimulation
TLR7
agonist
imiquimod
compared
controls.
production
IFN-γ,
II
IFN,
response
imiquimod.In
this
case
rare
putative
impaired
IFN
responses.
These
preliminary
findings
provide
insights
into
pathogenesis
BMC Infectious Diseases,
Journal Year:
2021,
Volume and Issue:
21(1)
Published: Aug. 21, 2021
Abstract
Background
Mortality
rates
of
coronavirus
disease-2019
(COVID-19)
continue
to
rise
across
the
world.
The
impact
several
risk
factors
on
mortality
has
been
previously
reported
in
meta‐analyses
limited
by
small
sample
sizes.
In
this
systematic
review,
we
aimed
summarize
available
findings
association
between
comorbidities,
complications,
smoking
status,
obesity,
gender,
age
and
D-dimer,
from
COVID-19
using
a
large
dataset
number
studies.
Method
Electronic
databases
including
Google
Scholar,
Cochrane
Library,
Web
Sciences
(WOS),
EMBASE,
Medline/PubMed,
Research
Database,
Scopus,
were
systematically
searched
till
31
August
2020.
We
included
all
human
studies
regardless
language,
publication
date
or
region.
Forty-two
with
total
423,117
patients
met
inclusion
criteria.
To
pool
estimate,
mixed-effect
model
was
used.
Moreover,
bias
sensitivity
analysis
evaluated.
Results
consistent
stating
contribution
age,
acute
kidney
injury,
D-dimer
as
factor
increase
requirement
for
advanced
medical
care.
results
showed
that
pooled
prevalence
among
hospitalized
17.62%
(95%
CI
14.26–21.57%,
42
patients).
Older
shown
increased
due
odds
ratio
(pOR)
hazard
(pHR)
2.61
1.75–3.47)
1.31
1.11–1.51),
respectively.
A
significant
found
male
(pOR
=
1.45;
95%
1.41–1.51;
pHR
1.24;
1.07–1.41),
current
smoker
1.42;
1.01–1.83).
Furthermore,
is
highly
influenced
Chronic
Obstructive
Pulmonary
Disease
(COPD),
Cardiovascular
(CVD),
diabetes,
hypertension,
obese,
cancer,
injury
D-dimer.
Conclusion
demographic
variables
COPD,
CVD,
older
smoker,
obesity
are
clinical
fatal
outcome
associated
coronavirus.
could
be
used
disease’s
future
research,
control
prevention.
The Lancet Respiratory Medicine,
Journal Year:
2021,
Volume and Issue:
9(6), P. 622 - 642
Published: May 7, 2021
The
zoonotic
SARS-CoV-2
virus
that
causes
COVID-19
continues
to
spread
worldwide,
with
devastating
consequences.
While
the
medical
community
has
gained
insight
into
epidemiology
of
COVID-19,
important
questions
remain
about
clinical
complexities
and
underlying
mechanisms
disease
phenotypes.
Severe
most
commonly
involves
respiratory
manifestations,
although
other
systems
are
also
affected,
acute
is
often
followed
by
protracted
complications.
Such
complex
manifestations
suggest
dysregulates
host
response,
triggering
wide-ranging
immuno-inflammatory,
thrombotic,
parenchymal
derangements.
We
review
intricacies
pathophysiology,
its
various
phenotypes,
anti-SARS-CoV-2
response
at
humoral
cellular
levels.
Some
similarities
exist
between
failure
origins,
but
evidence
for
many
distinctive
mechanistic
features
indicates
constitutes
a
new
entity,
emerging
data
suggesting
involvement
an
endotheliopathy-centred
pathophysiology.
Further
research,
combining
basic
studies,
needed
advance
understanding
pathophysiological
characterise
immuno-inflammatory
derangements
across
range
phenotypes
enable
optimum
care
patients
COVID-19.
Journal of Clinical Investigation,
Journal Year:
2020,
Volume and Issue:
130(11), P. 6141 - 6150
Published: Aug. 7, 2020
Convalescent
plasma
is
a
leading
treatment
for
coronavirus
disease
2019
(COVID-19),
but
there
paucity
of
data
identifying
its
therapeutic
efficacy.
Among
126
potential
convalescent
donors,
the
humoral
immune
response
was
evaluated
using
severe
acute
respiratory
syndrome
2
(SARS–CoV-2)
virus
neutralization
assay
with
Vero-E6-TMPRSS2
cells;
commercial
IgG
and
IgA
ELISA
to
detect
spike
(S)
protein
S1
domain
(EUROIMMUN);
IgA,
IgG,
IgM
indirect
ELISAs
full-length
S
or
receptor–binding
(S-RBD);
an
avidity
assay.
We
used
multiple
linear
regression
predictive
models
assess
correlations
between
antibody
responses
demographic
clinical
characteristics.
titers
were
greater
than
either
S1,
S,
S-RBD
in
overall
population.
Of
samples,
101
(80%)
had
detectable
neutralizing
(nAb)
titers.
Using
nAb
as
reference,
confirmed
95%–98%
nAb-positive
20%–32%
nAb-negative
samples
still
positive.
Male
sex,
older
age,
hospitalization
COVID-19
associated
increased
across
serological
assays.
There
substantial
heterogeneity
among
emerged
factors
that
can
be
identify
individuals
high
likelihood
having
strong
antiviral
responses.
Cancer Discovery,
Journal Year:
2020,
Volume and Issue:
10(6), P. 779 - 782
Published: April 10, 2020
TMPRSS2
is
both
the
most
frequently
altered
gene
in
primary
prostate
cancer
and
a
critical
factor
enabling
cellular
infection
by
coronaviruses,
including
SARS-CoV-2.
The
modulation
of
its
expression
sex
steroids
could
contribute
to
male
predominance
severe
infections,
given
that
has
no
known
indispensable
functions,
inhibitors
are
available,
it
an
appealing
target
for
prevention
or
treatment
respiratory
viral
infections.
Science Immunology,
Journal Year:
2021,
Volume and Issue:
6(62)
Published: Aug. 10, 2021
Autosomal
inborn
errors
of
type
I
IFN
immunity
and
autoantibodies
against
these
cytokines
underlie
at
least
10%
critical
COVID-19
pneumonia
cases.
We
report
very
rare,
biochemically
deleterious
X-linked
TLR7
variants
in
16
unrelated
male
individuals
aged
7
to
71
years
(mean:
36.7
years)
from
a
cohort
1,202
patients
0.5
99
52.9
with
unexplained
pneumonia.
None
the
331
asymptomatically
or
mildly
infected
1.3
102
38.7
tested
carry
such
(p
=
3.5
×
10-5).
The
phenotypes
five
hemizygous
relatives
index
cases
SARS-CoV-2
include
asymptomatic
mild
infection
(n=2,
5
38
years),
moderate
(n=1,
severe
27
29
Two
boys
(aged
12
262
51.0
are
for
variant.
cumulative
allele
frequency
general
population
is
<
6.5x10-4
also
show
that
blood
B
cell
lines
myeloid
subsets
do
not
respond
stimulation,
phenotype
rescued
by
wild-type
patients'
plasmacytoid
dendritic
cells
(pDCs)
produce
low
levels
IFNs
response
SARS-CoV-2.
Overall,
recessive
deficiency
highly
penetrant
genetic
etiology
pneumonia,
about
1.8%
below
age
60
years.
Human
pDCs
essential
protective
respiratory
tract.